A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling
Transplant Infectious Disease, EarlyView.
Source: Transplant Infectious Disease - Category: Transplant Surgery Authors: Barbara
Sarina
,
Jacopo
Mariotti
,
Stefania
Bramanti
,
Lucio
Morabito
,
Roberto
Crocchiolo
,
Andrea
Rimondo
,
Federica
Tordato
,
Daria
Pocaterra
,
Erminia
Casari
,
Chiara
De Philippis
,
Carmelo
Carlo ‐Stella
,
Source Type: research
More News: Fluconazole | Fungal Infections | Infectious Diseases | Stem Cell Therapy | Stem Cells | Transplant Surgery | Transplants